Skip to main content

CAPITAL FUND MANAGEMENT S.A.

Position in SRPT — Sarepta Therapeutics, Inc.

CIK 1323645 PARIS, I0

Position in SRPT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,812,144
-$4,182,702 QoQ
Shares Held
323,436
-29.6% QoQ
Ownership
0.306%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#49
of 323 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in SRPT Over Time

Shares Held

Position Value (USD)

Derivatives in SRPT

reported options exposure · as of Jun 30, 2026
CallValue
$451,047
CallShares
25,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CAPITAL FUND MANAGEMENT S.A. holds $326,278,392 across 42 Biotechnology names. SRPT ranks #13 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SRPT

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,812,144 323,436
2026-06-30 $451,047 25,100
2026-03-31 $1,414,400 65,000
2026-03-31 $9,994,846 459,322
2026-03-31 $411,264 18,900
2025-12-31 $3,292,560 153,000
2025-12-31 $2,425,304 112,700
2025-12-31 $10,446,948 485,453
2025-09-30 $2,626,501 136,300
2025-09-30 $15,031,640 780,054
2025-09-30 $4,437,881 230,300
2025-06-30 $762,660 44,600
2025-06-30 $8,802,139 514,745
2025-06-30 $1,058,490 61,900
2025-03-31 $12,772,743 200,137
2024-12-31 $21,125,654 173,745
2024-09-30 $25,495,793 204,146
2024-03-31 $5,162,994 39,881
2023-12-31 $7,299,365 75,696
2022-06-30 $1,126,498 15,028
2022-03-31 $2,803,179 35,883
2021-12-31 $1,567,950 17,412
2020-03-31 $970,667 9,923